Limitless Life Nootropics vs Peptide Partners
Independent side-by-side comparison across the 2 peptides both vendors sell. Composite scores, lab quality, and verified pricing.
Limitless Life Nootropics
14 peptides covered with 58 lab tests. BPC-157 averages 6.6 across 6 tests with consistency penalty triggered.
Limitless Life Nootropics full review →Peptide Partners
Peptide Partners ranks A overall on 71 lab tests across 7 peptides, with the Ipamorelin line (avg 9.9 across 7 tests) and Retatrutide line (avg 8.8 across 19 tests) carrying the score. Per-batch COAs are published with HPLC and mass spec; customer satisfaction sits at 4.8/5 acro…
Peptide Partners full review →Side-by-side breakdown
| PEPTIDE | LIMITLESS LIFE NOOTROPICS | PEPTIDE PARTNERS | WINNER |
|---|---|---|---|
| Ipamorelin |
7.2
B (4 tests)
|
9.9
A (7 tests)
|
Peptide Partners |
| GHK-Cu |
6.5
B (5 tests)
|
—(not sold)
|
Limitless Life Nootropics only |
| BPC-157 |
6.4
B (6 tests)
|
8.0
A (7 tests)
|
Peptide Partners |
| Semaglutide |
6.4
B (5 tests)
|
—(not sold)
|
Limitless Life Nootropics only |
| Retatrutide |
—(not sold)
|
8.8
B+ (19 tests)
|
Peptide Partners only |
| Tirzepatide |
—(not sold)
|
8.2
C (6 tests)
|
Peptide Partners only |
| TB-500 |
—(not sold)
|
8.1
A (11 tests)
|
Peptide Partners only |
| Tesamorelin |
—(not sold)
|
7.8
B+ (11 tests)
|
Peptide Partners only |
| CJC-1295 |
—(not sold)
|
6.7
C (9 tests)
|
Peptide Partners only |
Which to choose
Across the 2 peptides both vendors sell, Limitless Life Nootropics scores higher on 0, Peptide Partners scores higher on 2, and 0 are within 0.3 points (effectively tied). Peptide Partners additionally sells Retatrutide, Tirzepatide, TB-500, Tesamorelin, CJC-1295; Limitless Life Nootropics does not. Limitless Life Nootropics additionally sells GHK-Cu, Semaglutide; Peptide Partners does not.
Choose Peptide Partners for: Ipamorelin, BPC-157.
Composite scores reflect lab quality, sentiment, COA transparency, reliability, and price. How we score.
Full profiles: Limitless Life Nootropics review · Peptide Partners review